Abstract
Oxidised low-density lipoprotein (LDL) cholesterol is vasoconstrictor, mitogenic, pro-inflammatory and thrombogenic. This review summarises the evidence for its vasoconstrictor properties. LDL cholesterol potentiates noradrenaline vasoconstriction in the peripheral vasculature, and in the coronary, cerebral and renal vascular beds. There is also blunting of endothelium-dependent vasodilator responses to acetylcholine. These effects are reversed, or at least reduced, by lipid-lowering agents and (because LDL cholesterol down-regulates endothelial nitric oxide synthase) by the administration of L-arginine, the substrate for nitric oxide (NO) formation. Anti-oxidants also improve endothelial function in hypercholesterolaemic animals and human patients. More research is needed to assess the possible beneficial effects of lipid lowering on vascular structure and function, and on cardiovascular morbidity and mortality, in normocholesterolaemic individuals.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Bloom DS, McCalden TA, Rosendorff C . The effect of hypercholesterolemic plasma on vascular sensitivity to noradrenaline Br J Pharmacol 1975 54: 421–427
Bomzon L, Kew M, Rosendorff C . Renovascular hypersensitivity to noradrenaline in dietary-induced hypercholesterolemia in baboons Clin Exp Pharm Physiol 1978 5: 181–185
Rosendorff C et al. Cholesterol sensitizes coronary vessels to norepinephrine Circ Res 1981 48: 320–329
Gerhard M, Roddy M-A, Creager SJ, Creager MA . Aging progressively impairs endothelium-dependent vasodilation in forearm resistance vessels of humans Hypertension 1996 27: 849–853
Clarkson P et al. Impaired vascular reactivity in insulin-dependent diabetes mellitus is related to disease duration and low density lipoprotein cholesterollevels J Am Coll Cardiol 1996 23: 573–579
Zeiher AM et al. Coronary atherosclerotic wall thickening and vascular reactivity in humans. Elevated high-density lipoprotein levels ameliorate abnormal vasoconstriction in early atherosclerosis Circulation 1994 89: 525–532
Vogel RA, Coretti MC, Plotnick GD . Changes in flow-mediated brachial artery vasoactivity with lowering of desirable cholesterol levels in healthy middle-aged men Am J Cardiol 1996 77: 37–40
Tamai O et al. Single LDL apheresis improves endothelium-dependent vasodilation in hypercholesterolemic humans Circulation 1997 95: 76–82
Wang B-Y et al. Arginine restores nitric oxide activity and inhibits monocyte accumulation after vascular injury in hypercholesterolemic rabbits J Am Coll Cardiol 1996 28: 1573–1579
Singer AH et al. Discordant effects of dietary L-arginine on vascular structure and reactivity in hypercholesterolemic rabbits J Cardiovasc Pharmacol 1995 25: 710–716
Stroes ESG, Koomans HA, de Bruin TWA, Rabelink TJ . Vascular function in the forearm of hypercholesterolemicpatients off and on lipid lowering medication Lancet 1995 346: 167–171
Laufs U, La Fata V, Plutzky J, Liao JK . Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors Circulation 1998 97: 1129–1135
Andersson TL, Matz J, Ferns GA, Anggard EE . Vitamin E reverses cholesterol induced endothelial dysfunction in the rabbit circulation Atherosclerosis 1994 111: 39–45
Ting HH et al. Vitamin C improves endothelium-dependent vasodilation in forearm resistance vessels of humans with hypercholesterolemia Circulation 1997 96: 2617–2622
Treasure CB et al. Beneficial effects of cholesterol-lowering therapy on the coronary endothelium inpatients with coronary artery disease N Engl J Med 1995 332: 481–487
Anderson TJ et al. The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion N Engl J Med 1995 332: 488–493
Rapola JM et al. Randomized trial of alpha-tocopherol and beta-carotene supplements on coronary events in men with previous myocardial infarction Lancet 1997 349: 1715–1720
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Rosendorff, C. Effects of LDL cholesterol on vascular function. J Hum Hypertens 16 (Suppl 1), S26–S28 (2002). https://doi.org/10.1038/sj.jhh.1001337
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.jhh.1001337
Keywords
This article is cited by
-
Caffeic Acid Protects against Iron-Induced Cardiotoxicity by Suppressing Angiotensin-Converting Enzyme Activity and Modulating Lipid Spectrum, Gluconeogenesis and Nucleotide Hydrolyzing Enzyme Activities
Biological Trace Element Research (2021)
-
Patients with early age-related macular degeneration exhibit signs of macro- and micro-vascular disease and abnormal blood glutathione levels
Graefe's Archive for Clinical and Experimental Ophthalmology (2014)
-
Beyond Lipid Lowering: The Anti-Hypertensive Role of Statins
Cardiovascular Drugs and Therapy (2007)